Development and Validation of a Dynamic Nomogram for Predicting 3-Month Mortality in Acute Ischemic Stroke Patients with Atrial Fibrillation
Xiaodi Yan,Peng Xia,Hanwen Tong,Chen Lan,Qian Wang,Yujie Zhou,Huaijun Zhu,Chenxiao Jiang
DOI: https://doi.org/10.2147/rmhp.s442353
2024-01-17
Risk Management and Healthcare Policy
Abstract:Xiaodi Yan, 1, 2 Peng Xia, 3 Hanwen Tong, 4 Chen Lan, 1, 2 Qian Wang, 1, 2 Yujie Zhou, 5, &ast Huaijun Zhu, 6 Chenxiao Jiang 6, &ast 1 Department of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China; 2 School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China; 3 Department of Pharmacy, Nanjing Drum Tower Hospital, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China; 4 Department of Emergency Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, People's Republic of China; 5 Department of Respiratory Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, People's Republic of China; 6 Department of Pharmacy, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chenxiao Jiang; Yujie Zhou, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, Jiangsu, People's Republic of China, Tel +86 177 6173 2923 ; +86 137 0140 9863, Email ; Background: Acute ischemic stroke (AIS) in patients with atrial fibrillation (AF) carries a substantial risk of mortality, emphasizing the need for effective risk assessment and timely interventions. This study aimed to develop and validate a practical dynamic nomogram for predicting 3-month mortality in AIS patients with AF. Methods: AIS patients with AF were enrolled and randomly divided into training and validation cohorts. The nomogram was developed based on independent risk factors identified by multivariate logistic regression analysis. The prediction performance of the nomogram was evaluated using the area under the receiver operating characteristic curve (AUC-ROC), calibration plots, decision curve analysis (DCA), and Kaplan-Meier survival analysis. Results: A total of 412 patients with AIS and AF entered final analysis, 288 patients in the training cohort and 124 patients in the validation cohort. The nomogram was developed using age, baseline National Institutes of Health Stroke Scale score, early introduction of novel oral anticoagulants, and pneumonia as independent risk factors. The nomogram exhibited good discrimination both in the training cohort (AUC, 0.851; 95% CI, 0.802– 0.899) and the validation cohort (AUC, 0.811; 95% CI, 0.706– 0.916). The calibration plots, DCA and Kaplan-Meier survival analysis demonstrated that the nomogram was well calibrated and clinically useful, effectively distinguishing the 3-month survival status of patients with AIS and AF, respectively. The dynamic nomogram can be obtained at the website: https://yanxiaodi.shinyapps.io/3-monthmortality/ . Conclusion: The dynamic nomogram represents the first predictive model for 3-month mortality and may contribute to managing the mortality risk of patients with AIS and AF. Keywords: dynamic nomogram, mortality, acute ischemic stroke, atrial fibrillation Stroke, the most common type of which is acute ischemic stroke (AIS), is a major threat to health in China as it is the leading cause of death and the prevalence is on the rise. 1 According to the Global Burden of Disease (GBD) Study 2019, China accounts for 2.19 million of the 6.55 million stroke-related deaths worldwide. 2 Atrial fibrillation (AF) stands out as a primary risk factor for AIS, significantly elevating the risk of AIS occurrence and associated mortality. 3,4 Previous studies indicated that patients with AF are five times more likely to experience AIS, often resulting in high mortality within the first 30 days following onset, with figures ranging from 22% to 27%. 5–7 This represents a substantial public health concern. While anticoagulant therapy is recommended and acknowledged as an effective approach for reducing mortality in AIS patients with AF, a notable disparity exists between clinical practices and guideline recommendations. 8–11 Consequently, the potential benefits of lowering mortality risk through anticoagulant therapy have not been fully realized. 12,13 Therefore, the early identification of factors influencing mortality risk is of paramount importance to facilitate timely interventions and prolong patient -Abstract Truncated-
health care sciences & services,health policy & services